Imperial Blue lifts Tilaknagar revenue 165%, but PAT falls 64% to ₹32 Cr on integration costs

Tilaknagar Industries' first full quarter with the acquired Imperial Blue (IB) business transformed its scale but not yet its profit. Consolidated revenue from operations rose ~165% YoY to ₹2,252 Cr (net of ₹1,206 Cr excise duty, ~₹1,046 Cr), driven entirely by the IB division bought from Pernod Ricard for ₹3,442 Cr (completed Dec 2025). Consolidated PAT, however, fell to ₹31.6 Cr from ₹88.5 Cr a year ago — down ~64% reported, and still down ~30% even after excluding the ₹30.1 Cr exceptional charge for IB integration and transition costs. So the revenue explosion is inorganic and the bottom line went backwards on a like-for-like basis.

The margin bridge explains the gap. Operating EBITDA of ~₹173 Cr translates to roughly 16% of net revenue — landing at the lower end of the 16–18% band management/brokerages have guided for FY27, consistent with the "margins near the low end" framing given near-term raw-material inflation. Below EBITDA, two acquisition-driven lines crush the print: finance costs jumped to ₹66.4 Cr (from ₹2.8 Cr a year ago) on the debt funding the deal, and depreciation rose to ₹45.5 Cr (from ₹7.3 Cr). Tax expense was nil. The result is a profit that is thin relative to the enlarged asset and debt base — the classic shape of an integration year.

The stock went into the print at ₹446.7, up 2.4% over the past month of trading.

Standalone PAT ₹33.3 Cr on revenue ₹2,252 Cr (EPS ₹1.35) — broadly in line with consolidated

Sequentially the quarter reads better: revenue grew ~8% QoQ and the company swung back to a ₹31.6 Cr profit from a ₹14.9 Cr consolidated loss in Q4 FY26, when exceptional costs peaked. Operationally momentum is real — June 2026 saw a record 3.4 million cases and IB crossed 2 million cases in both May and June — which supports management's high-single to low-double-digit FY27 volume guide. Concurrent board actions this quarter fit the integration theme: approval of a composite amalgamation of two wholly-owned subsidiaries (Punjabexpo Breweries, Vahni Distilleries; appointed date 1 Apr 2026, pending NCLT), incorporation of a Nigeria WOS, and the addition of an independent director. No published Q1 street consensus was found, so the print is best judged against guidance rather than a number: margins met the low end, volumes are tracking, but reported profitability remains suppressed until integration costs roll off and the ₹3,442 Cr acquisition debt is worked down (management targets net debt/EBITDA below 1.0x by FY29). The auditor's qualified conclusion on the un-assessed ENA-plant impairment is an outstanding governance flag, not a P&L event this quarter.